FDI Clinical Research
Hospitals & Physicians Clinics · Puerto Rico, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
998 Ave Munoz Rivera, San Juan, Puerto R...Phone Number
(787) 722-1248Website
www.fdiclinicalresearch.comRevenue
$5.7 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About FDI Clinical Research
FDI Clinical Research is a renowned clinical research center located in San Juan, Puerto Rico, specializing in innovative treatments for various health conditions. The company offers free evaluations for fatty liver disease and conducts advanced research in oncology, immunology, and other therapeutic areas. Their expert team comprises professionals with over 20 years of experience, ensuring excellence in clinical services. FDI aims to serve patients across Puerto Rico in their pursuit of effective medical solutions.Explore more
FDI Clinical Research Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is FDI Clinical Research your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if FDI Clinical Research has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once FDI Clinical Research has new funding data
Click to see if FDI Clinical Research had a recent Job posting/layoffs
Earning: See what the market has to say on FDI Clinical Research recently announced quarterly report
FDI Clinical Research, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at FDI Clinical Research
Check out if FDI Clinical Research is spiking on competitors!
Product Launch: Get notified when FDI Clinical Research launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at FDI Clinical Research
Find 3 more new buyers
Compare Similar Companies to FDI Clinical Research
Compare insights from companies similar to FDI Clinical Research, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
FDI Clinical Research is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.
What does this means?
FDI Clinical Research is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about FDI Clinical Research.
FDI Clinical Research financials insights
Gather financial insights about FDI Clinical Research, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
FDI Clinical Research Tech Stack
A closer look at the technologies used by FDI Clinical Research
FDI Clinical Research News & Media
Veritas Enrolls First Patient in Clinical Study to Assess Pain Control with Lead Product
SAN JUAN, Puerto Rico, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Puerto Rico LLC, a wholly owned subsidiary of Veritas Pharma, Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), today announced the dosing of the first adult volunteer in its clinical trial of their lead cannabis product (“CTL-X”) for the treatment of acute pain. The randomized, double-blinded crossover trial will assess the safety, tolerability and efficacy of CTL-X as a single dose vaporizedVeritas leads Puerto Rico partnership with approval of new Investigation License
SAN JUAN, Puerto Rico, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharma, Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), in partnership with the Institute for Medical Cannabis (“IMC”) and the Fundación de Investigación (“FDI”) were approved this past Friday for an Investigation License from the Commonwealth of Puerto Rico Medicinal Cannabis Regulatory Board allowing clinical evaluation of their lead cannabis product (“CTInvestors Could Reap Global Rewards of Research Into Medical Cannabis Science
NEW YORK, November 30, 2017 /PRNewswire/ -- With cannabis set to become legal for recreational use in July 2018 in Canada, and usage of the product for medical purposes steadily rising both in Canada and worldwide, cannabis companies have ramped up their efforts to make new scientific...Therapeutic Advancements in Breakthrough Therapies for Treating Chronic Pain Take aim at Reducing Opioid use
PALM BEACH, Florida, November 20, 2017 /PRNewswire/ -- A new study conducted by researchers at the University of New Mexico, involving medical cannabis and prescription opioid use among chronic pain patients, found a distinct connection between having the legal ability to use cannabis...
Read more news
Top Hospitals & Physicians Clinics Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding FDI Clinical Research
Sign Up For FreeTo access detailed company insights
FDI Clinical Research is a renowned clinical research center located in San Juan, Puerto Rico, specializing in innovative treatments for various health conditions. The company offers free evaluations for fatty liver disease and conducts advanced research in oncology, immunology, and other therapeutic areas. Their expert team comprises professionals... Read More
